Bukwang Pharm wins clinical trial approval for COVID-19 treatment
SEOUL, April 14 (Yonhap) -- South Korean pharmaceutical firm Bukwang Pharm Co. has won approval for clinical trials of its treatment drug for the novel coronavirus, industry sources said Tuesday.
The Ministry of Food and Drug Safety has given the green light to the second-phase clinical trial for Levovir, a hepatitis B infection treatment, they said.
It marks the first time that a local company will conduct clinical trials of a treatment drug on patients infected with COVID-19.
A total of 60 COVID-19 patients will be administered with Levovir to show efficacy and safety.
Levovir, an antiviral drug that won sales approval in 2006, is the world's fourth hepatitis B virus drug. It inhibits the replication of viral genetic materials.
The company earlier said Lenovivr showed similar results to AIDS treatment Kaletra, which is used to treat COVID-19 patients during in-vitro tests of viruses.
khj@yna.co.kr
(END)
-
(URGENT) Russian, Chinese warplanes enter S. Korea's air defense zone without notice: JCS
-
BTS to meet Biden at White House to discuss anti-Asian hate crimes
-
Premier League Golden Boot winner Son Heung-min receives hero's welcome home
-
Multiple Russian, Chinese warplanes enter KADIZ without notice: JCS
-
Hyundai Motor to invest US$5 bln in U.S. for robotics, autonomous driving development
-
(5th LD) Yoon, Biden agree to expand joint military exercises to cope with N.K. threats
-
(LEAD) Multiple Russian, Chinese warplanes enter KADIZ without notice: JCS
-
(LEAD) Biden set to arrive in S. Korea for first summit with Yoon
-
With historic Golden Boot, Son Heung-min cements case as greatest S. Korean footballer ever
-
(URGENT) Russian, Chinese warplanes enter S. Korea's air defense zone without notice: JCS
-
BTS to meet Biden at White House to discuss anti-Asian hate crimes
-
(LEAD) Supreme Court rules against peak wage system
-
S. Korean volunteer fighter in Ukraine returning home
-
'The Roundup' becomes most-watched Korean film in pandemic era
-
(LEAD) Yoon picks women for last remaining 2 Cabinet ministers